跳至主要内容
临床试验/NCT01475643
NCT01475643已完成3 期

Safety and Efficacy of Topical Loteprednol Etabonate 0.5%, Versus Prednisolone Acetate 1%, for the Treatment of Intraocular Inflammation Following Surgery for Childhood Cataract

Bausch & Lomb Incorporated1 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2013年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
107
试验地点
1
主要终点
Anterior Chamber Inflammation

研究概览

简要总结

The objective of this study is to compare the efficacy and safety for the treatment of postoperative inflammation following ocular surgery for childhood cataract.

详细描述

The objective of this study is to compare the efficacy and safety of topical Loteprednol Etabonate (LE), 0.5%, to Prednisolone Acetate 1%, for the treatment of postoperative inflammation following ocular surgery for childhood cataract.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
— 至 11 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Subject is a candidate for routine, uncomplicated surgery for childhood cataract

排除标准

  • Subjects who have a severe/serious ocular condition, or any other unstable medical condition that, in the Investigator's opinion, may preclude study treatment or follow-up.
  • Subjects with glaucoma, ocular hypertension, or those receiving intraocular pressure (IOP) lowering therapy in either eye or systemically.
  • Subjects with a history of steroid-induced IOP elevation in either eye.
  • Subjects who have known hypersensitivity or other contraindication to the study drug(s) or any components in the drug formulation.

研究组 & 干预措施

Loteprednol etabonate

Experimental

Loteprednol etabonate 0.5%

干预措施: Loteprednol etabonate (Drug)

Prednisolones acetate

Active Comparator

Prednisolone acetate 1.0%

干预措施: Prednisolones acetate (Drug)

结局指标

主要结局

Anterior Chamber Inflammation

时间窗: Postoperative Day 29

Anterior Chamber Inflammation (for subjects that could only be examined with a pen light and a 20D \[g20 Diopter\] magnifying lens): 0 = None Clear anterior chamber with no visible clouding (Tyndall effect and cells combined). Red reflex normal 1. = Mild Mild anterior chamber clouding. Clear iris pattern on visualization. Red reflex normal 2. = Moderate Moderate anterior chamber clouding 3. = Severe Severe anterior chamber clouding. Iris pattern not clearly visualized. Red reflex diminished 4. = Very severe Severe anterior chamber clouding with a white and/or milky appearance of the anterior chamber. Red reflex absent or severely diminished

次要结局

  • Anterior Chamber Cells & Flare(Over all visits 42 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验